Literature DB >> 1459672

Effect of three antibacterial drugs in lowering blood & stool ammonia production in hepatic encephalopathy.

T Alexander1, K Thomas, A M Cherian.   

Abstract

Neomycin (700 mg/8 h), ampicillin (500/6 h) and metronidazole (400 mg/8 h), were compared for their effect, on oral administration for 4 days, in reducing blood ammonia in 27 patients with stable chronic liver disease. It was found that there was 38.2, 38.5 and 8.7 m mol/litre mean reduction in blood ammonia in the neomycin, ampicillin and metronidazole treated groups respectively. The difference in blood ammonia was statistically significant for both neomycin (P = 0.01) and ampicillin (P = 0.03) but there was no significant change after metronidazole treatment (P = 0.6). The total stool enzyme activity at optimum pH was maximally reduced by ampicillin and minimally with metronidazole. The reduction was noted to be 3.51 m mol/1 (P = 0.01), 3.87 m mol/1 (P = 0.08) and 2.8 m mol/1 (P = 0.02) of NH3/g dry weight of stool for neomycin, ampicillin and metronidazole respectively. The main bacterial gut enzymes responsible for ammonia production, urease and protease, were found to be very sensitive to stool pH. At pH 6 their activity was around 20 per cent of what was found in optimum pH of 7.4 and at pH 5 it is only about 8 per cent of optimum activity. None of the three antibacterial agents changed the stool pH significantly. It can be concluded that oral neomycin and ampicillin are superior to oral metronidazole in lowering blood ammonia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459672

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  4 in total

1.  Alcoholic Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

2.  Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.

Authors:  H Miyaji; S Ito; T Azuma; Y Ito; Y Yamazaki; Y Ohtaki; F Sato; M Hirai; M Kuriyama; Y Kohli
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

3.  Engineering the gut microbiota to treat hyperammonemia.

Authors:  Ting-Chin David Shen; Lindsey Albenberg; Kyle Bittinger; Christel Chehoud; Ying-Yu Chen; Colleen A Judge; Lillian Chau; Josephine Ni; Michael Sheng; Andrew Lin; Benjamin J Wilkins; Elizabeth L Buza; James D Lewis; Yevgeny Daikhin; Ilana Nissim; Marc Yudkoff; Frederic D Bushman; Gary D Wu
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

4.  Comparison of diet, lactulose, and metronidazole combinations in the control of pre-surgical clinical signs in dogs with congenital extrahepatic portosystemic shunts.

Authors:  Goncalo Serrano; Nausikaa Devriendt; Hilde de Rooster; Dominique Paepe
Journal:  J Vet Intern Med       Date:  2022-05-28       Impact factor: 3.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.